Investor Type | Firm |
Type of Fund | VC |
Industries | PropTech • Other • BioTech • AgroTech • Businesses Solutions • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Analytics • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • DeepTech • Healthcare (& Wellness) • Investment Management • Mobility • Consumer • Woman Focused |
Stages | Pre-Seed, Seed, Series A, Latin America |
Investing | United States • Canada • Europe |
Investment Range | $250,000 - $1,000,000 |
Investment Sweet Spot | $750,000 |
Assets Under Management | $50,000,000 |
Creative Ventures is a venture capital firm that focuses on early-stage investments across a wide range of sectors including PropTech, BioTech, AgroTech, Business Solutions, Hardware and Manufacturing, Energy, Retail and E-Commerce, CleanTech, AI and Big Data, HealthTech and Fitness, Analytics, Food & Beverage, Material Science, Medical Devices and Hospital Services, Robotics, Real Estate and Construction, DeepTech, Healthcare and Wellness, Investment Management, Mobility, Consumer, and Woman Focused initiatives. Founded in 2016 and headquartered in San Francisco, California, USA, they operate with an understanding of the changing landscapes of these industries and the opportunities that arise from technological advancement and innovation. With assets under management worth $50 million, Creative Ventures defines its investment sweet spot at $1.5 million, while it considers funding companies requiring between $100,000 and $5,000,000. Their team specializes in Pre-Seed, Seed, Series A investments, and has a particular interest in supporting ventures in Latin America. Creative Ventures boasts a diverse portfolio showcasing companies like 3E Nano, Airworks, ALICE, AM Batteries, Bleximo, and C.Light, among others, reflecting their commitment to fostering growth in automation, construction, energy, healthcare, manufacturing, and innovative technologies that include quantum computers, immunotherapeutics for medical conditions, and robotic solutions. Their website features a portfolio section which further indicates a strategic focus on select startups with transformative potential and the ability to address real-world problems including drug discovery, disease treatment, and improving safety protocols through advanced technology.